LIG4 has been implicated in PC progression and therapeutic response, including urogenital radiotoxicity [141], although the precise role and clinical significance of LIG4 alterations in PC remain to be fully elucidated [113,141]. This evidence concerns the gene LIG4 and pachyonychia congenita.